Kythera Biophrm (KYTH) Recieves Interest After Buying Back Rights to ATX-101 - Bloomberg
Tweet Send to a Friend
Kythera Biophrm (NASDAQ: KYTH) received a lot of "in-bound interest ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
